Location History:
- both Chesterfield, MO (US) (1989)
- Ballwin, MO (US) (1993)
- Chestefield, MO (US) (1993)
- Chesterfield, MO (US) (1981 - 1995)
Company Filing History:
Years Active: 1981-1995
Title: Innovations by Youlin Lin in Magnetic Resonance Imaging
Introduction
Youlin Lin, based in Chesterfield, MO, is a notable inventor with an impressive portfolio of 19 patents. His work primarily focuses on advancements in magnetic resonance imaging (MRI), contributing significantly to the field of medical diagnostics.
Latest Patents
Among Youlin Lin's latest inventions are several pivotal patents. One of his key innovations is the development of "Iodo-phenylated chelates for magnetic resonance imaging," which represents hybrid agents aimed at enhancing in vivo diagnostic imaging of body organs and tissues. Another significant patent is the "Trifluoromethyl analogs of X-ray contrast media for magnetic resonance," which discusses methods and compositions designed to improve fluorine-19 magnetic resonance imaging using trifluoromethyl derivatives of iodinated X-ray contrast media. This innovation includes specific bis-, tri-, and tetrakis(trifluoromethyl)benzene derivatives and other related compounds.
Career Highlights
Youlin Lin's career features notable positions at recognized companies such as Mallinckrodt Medical, Inc. and Mallinckrodt, Inc. His contributions have played a crucial role in the advancement of diagnostic imaging technologies, leaving a significant impact in this domain.
Collaborations
Throughout his career, Lin has collaborated with esteemed colleagues, including David H. White and Mills T. Kneller. These collaborative efforts have fostered innovation and propelled advancements in the medical imaging field.
Conclusion
Youlin Lin's extensive body of work and his innovative contributions to magnetic resonance imaging technology underscore his status as a leading inventor in the field. His patents not only enhance imaging capabilities but also contribute to better diagnostic outcomes in medical practice.